Survey of northeastern hop arthropod pests and their natural enemies

The commercial production of hops (Humulus lupulus L.) in the northeastern United States is on the rise due to demand from local breweries. Several arthropod pests are economically damaging to hop yield and quality. Due to climate and landscape differences between traditional and resurging hop-growing regions, there is a need for region-specific integrated pest management (IPM). We first review hop pest and natural enemy biology and management strategies. Then the phenology, abundance, and peak date of arthropod pests scouted in seven Vermont hop yards is reported. Documentation of natural enemy abundance is also reported. Our 3-yr survey indicated that hop aphid (Phorodon humuli (Schrank)) populations were highest in the continually cool, wet season. Potato leafhopper (Empoasca fabae (Harris)) was a pest with an unpredictable arrival date and of special concern for first-year hop plants. Twospotted spider mite (Tetranychus urticae Koch) was a pest of concern in hot, dry conditions and after some broad-spectrum pesticide applications aimed at leafhoppers. This survey was the first step toward developing appropriate IPM tactics for modern day northeastern hop production. Further research should be focused on adjusting arthropod pest thresholds, disease management, and developing alternative control options for both arthropod and disease management

High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer

Recently, we reported that high soluble Hsp70 (sHsp70) level was a significant predictor of mortality during an almost 3-year-long follow-up period in patients with colorectal cancer. This association was the strongest in the group of <70-year-old female patients as well as in those who were in a less advanced stage of the disease at baseline. According to these observations, measurement of the serum level of sHsp70 is a useful, stage-independent prognostic marker in colorectal cancer, especially in patients without distant metastasis. Since many literature data indicated that measurement of C-reactive protein (CRP) and other acute phase proteins (APPs) may also be suitable for predicting the mortality of patients with colorectal cancer, it seemed reasonable to study whether the effect of sHsp70 and other APPs are related or independent. In order to answer this question, we measured the concentrations of CRP as well as of other complement-related APPs (C1 inhibitor, C3, and C9) along with that of the MASP-2 complement component in the sera of 175 patients with colorectal cancer and known levels of sHsp70, which have been used in our previous study. High (above median) levels of CRP, C1 esterase inhibitor (C1-INH), and sHsp70 were found to be independently associated with poor patient survival, whereas no such association was observed with the other proteins tested. According to the adjusted Cox proportional hazards analysis, the additive effect of high sHsp70, CRP, and C1-INH levels on the survival of patients exceeded that of high sHsp70 alone, with a hazard ratio (HR) of 2.83 (1.13–70.9). In some subgroups of patients, such as in females [HR 4.80 (1.07–21.60)] or in ≤70-year-old patients [HR 11.53 (2.78–47.70)], even greater differences were obtained. These findings indicate that the clinical mortality–prediction value of combined measurements of sHsp70, CRP, and C1-INH with inexpensive methods can be very high, especially in specific subgroups of patients with colorectal cancer